williamson biotech solutions limited
williamson biotech solutions limited Company Information
Company Number
10175635
Next Accounts
Feb 2026
Industry
Non-trading company
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Directors
Shareholders
jeanne-franooise williamson
philip williamson
Group Structure
View All
Contact
Registered Address
67 chessel avenue, southampton, hampshire, SO19 4DY
williamson biotech solutions limited Estimated Valuation
Pomanda estimates the enterprise value of WILLIAMSON BIOTECH SOLUTIONS LIMITED at £34.2k based on a Turnover of £61.7k and 0.55x industry multiple (adjusted for size and gross margin).
williamson biotech solutions limited Estimated Valuation
Pomanda estimates the enterprise value of WILLIAMSON BIOTECH SOLUTIONS LIMITED at £0 based on an EBITDA of £-9k and a 6.13x industry multiple (adjusted for size and gross margin).
williamson biotech solutions limited Estimated Valuation
Pomanda estimates the enterprise value of WILLIAMSON BIOTECH SOLUTIONS LIMITED at £26.2k based on Net Assets of £13k and 2.01x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Williamson Biotech Solutions Limited Overview
Williamson Biotech Solutions Limited is a live company located in hampshire, SO19 4DY with a Companies House number of 10175635. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in May 2016, it's largest shareholder is jeanne-franooise williamson with a 91% stake. Williamson Biotech Solutions Limited is a young, micro sized company, Pomanda has estimated its turnover at £61.7k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Williamson Biotech Solutions Limited Health Check
Pomanda's financial health check has awarded Williamson Biotech Solutions Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
7 Weak
Size
annual sales of £61.7k, make it smaller than the average company (£2m)
- Williamson Biotech Solutions Limited
£2m - Industry AVG
Growth
3 year (CAGR) sales growth of -6%, show it is growing at a slower rate (9.3%)
- Williamson Biotech Solutions Limited
9.3% - Industry AVG
Production
with a gross margin of 47.3%, this company has a comparable cost of product (47.3%)
- Williamson Biotech Solutions Limited
47.3% - Industry AVG
Profitability
an operating margin of -16.7% make it less profitable than the average company (6.5%)
- Williamson Biotech Solutions Limited
6.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (21)
1 - Williamson Biotech Solutions Limited
21 - Industry AVG
Pay Structure
on an average salary of £48.6k, the company has an equivalent pay structure (£48.6k)
- Williamson Biotech Solutions Limited
£48.6k - Industry AVG
Efficiency
resulting in sales per employee of £61.7k, this is less efficient (£133.1k)
- Williamson Biotech Solutions Limited
£133.1k - Industry AVG
Debtor Days
it gets paid by customers after 37 days, this is earlier than average (52 days)
- Williamson Biotech Solutions Limited
52 days - Industry AVG
Creditor Days
its suppliers are paid after 10 days, this is quicker than average (32 days)
- Williamson Biotech Solutions Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Williamson Biotech Solutions Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 61 weeks, this is more cash available to meet short term requirements (32 weeks)
61 weeks - Williamson Biotech Solutions Limited
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 72.3%, this is a higher level of debt than the average (48.6%)
72.3% - Williamson Biotech Solutions Limited
48.6% - Industry AVG
WILLIAMSON BIOTECH SOLUTIONS LIMITED financials
Williamson Biotech Solutions Limited's latest turnover from May 2024 is estimated at £61.7 thousand and the company has net assets of £13 thousand. According to their latest financial statements, Williamson Biotech Solutions Limited has 1 employee and maintains cash reserves of £40.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | ||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 287 | 1,602 | 1,230 | 1,293 | 1,792 | 192 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 287 | 1,602 | 1,230 | 1,293 | 1,792 | 192 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 6,359 | 3,999 | 12,156 | 13,098 | 2,404 | 2,160 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 3 | 1 | 865 | 1,671 | 1 | 100 | 0 |
| Cash | 40,319 | 45,250 | 29,086 | 33,327 | 19,573 | 2,427 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 46,678 | 49,252 | 41,243 | 47,290 | 23,648 | 4,588 | 100 | 0 |
| total assets | 46,965 | 50,854 | 42,473 | 48,583 | 25,440 | 4,780 | 100 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 945 | 306 | 0 | 25 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 32,993 | 29,460 | 28,180 | 30,561 | 25,026 | 4,648 | 0 | 0 |
| total current liabilities | 33,938 | 29,766 | 28,180 | 30,586 | 25,026 | 4,648 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 33,938 | 29,766 | 28,180 | 30,586 | 25,026 | 4,648 | 0 | 0 |
| net assets | 13,027 | 21,088 | 14,293 | 17,997 | 414 | 132 | 100 | 0 |
| total shareholders funds | 13,027 | 21,088 | 14,293 | 17,997 | 414 | 132 | 100 | 0 |
| May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | 1,315 | 1,315 | 894 | 686 | 639 | 125 | 0 | |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Tax | ||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 2,357 | -8,155 | -1,806 | 9,888 | 1,914 | 2,061 | 100 | 0 |
| Creditors | 639 | 306 | -25 | 25 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 3,533 | 1,280 | -2,381 | 5,535 | 20,378 | 4,648 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | -4,931 | 16,164 | -4,241 | 13,754 | 17,146 | 2,427 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -4,931 | 16,164 | -4,241 | 13,754 | 17,146 | 2,427 | 0 | 0 |
williamson biotech solutions limited Credit Report and Business Information
Williamson Biotech Solutions Limited Competitor Analysis
Perform a competitor analysis for williamson biotech solutions limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in SO19 area or any other competitors across 12 key performance metrics.
williamson biotech solutions limited Ownership
WILLIAMSON BIOTECH SOLUTIONS LIMITED group structure
Williamson Biotech Solutions Limited has no subsidiary companies.
Ultimate parent company
WILLIAMSON BIOTECH SOLUTIONS LIMITED
10175635
williamson biotech solutions limited directors
Williamson Biotech Solutions Limited currently has 1 director, Dr Jeanne-Francoise Williamson serving since May 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Jeanne-Francoise Williamson | United Kingdom | 54 years | May 2016 | - | Director |
P&L
May 2024turnover
61.7k
+24%
operating profit
-10.3k
0%
gross margin
47.4%
+2.36%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2024net assets
13k
-0.38%
total assets
47k
-0.08%
cash
40.3k
-0.11%
net assets
Total assets minus all liabilities
williamson biotech solutions limited company details
company number
10175635
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
74990 - Non-trading company
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
May 2016
age
9
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
May 2024
previous names
N/A
accountant
ANDREW JENVEY AIMS ACCOUNTANTS FOR BUSINESS
auditor
-
address
67 chessel avenue, southampton, hampshire, SO19 4DY
Bank
-
Legal Advisor
-
williamson biotech solutions limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to williamson biotech solutions limited.
williamson biotech solutions limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for WILLIAMSON BIOTECH SOLUTIONS LIMITED. This can take several minutes, an email will notify you when this has completed.
williamson biotech solutions limited Companies House Filings - See Documents
| date | description | view/download |
|---|
